Remove Doctors Remove Medical Schools Remove Therapies
article thumbnail

Zebrafish for Disease Modeling and Drug Screening in Pediatric Cancers

biobide

Children and adolescents lack robust preclinical models to replicate the pathologies and provide precise and targeted therapies. This is why not many Pharma companies specifically specialize in discovering and developing pediatric cancer treatments; a great example of advancing new therapies for childhood cancer is the biotech Oncoheroes.

Disease 59
article thumbnail

Study reveals how cancer immunotherapy may cause heart inflammation in some patients

Broad Institute

We are incredibly grateful to each and every patient who partnered with us, all those involved in their clinical care, and the exceptional team in our lab who made this research possible.” “This work provides a biological foundation for testing more targeted therapies for myocarditis due to an immune checkpoint inhibitor.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Q&A: How a partnership between physicians and researchers aims to make cancer drugs safer

Broad Institute

Earlier this year, the researchers shared their first translational results, describing the immune cell response underlying colon inflammation in patients undergoing ICI therapy. These are home-run, breakthrough therapies, and quite an amazing success story. How big of a problem are these complications from cancer immunotherapy?

Research 124
article thumbnail

Multi-ancestry study reveals genetic risk factors for two common pregnancy complications

Broad Institute

The scores could help doctors identify and treat at-risk individuals earlier in pregnancy with existing but underutilized strategies such as low-dose aspirin. They also developed polygenic risk scores, which distill a person’s likelihood of developing a condition down to a single number based on their genes.

Doctors 133
article thumbnail

Not all neoantigens are created equal

Drug Target Review

In most cancers, the tumour evolves by acquiring mutations that confer growth advantages or resistance to therapies. However, if the therapy targets only the subclonal (branch) mutations, this will result in the mere ‘pruning’ of specific branches rather than elimination of the whole cancer.

article thumbnail

Mediating BRAF-mutant melanoma resistance

Drug Target Review

Regarding therapy resistant melanomas, why is the alteration of the epigenetic landscape considered significant, and what has been lacking in terms of validated targetable epigenetic mechanisms? What is remarkable here is that we show that the addition of corin to BRAFi-resistant tumour cells resensitises them to BRAFi therapies.

article thumbnail

Vision Problems? Here’s a Guide to Which Specialist Is Right for You

The Pharma Data

Ophthalmologists are physicians who have completed four years of medical school and four years of residency training. They aren’t doctors, according to the American Association of Certified Orthoptists. Treatments they help administer include patching therapy, prisms and convergence exercises. © 2021 HealthDay.